SDIC
NKTR icon

South Dakota Investment Council’s Nektar Therapeutics NKTR Stock Holding History

South Dakota Investment Council’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,004
Closed -$162K – 633
2022
Q1 		$162K Hold
2,004
– – ﹤0.01% 558
2021
Q4 		$406K Hold
2,004
– – 0.01% 543
2021
Q3 		$540K Hold
2,004
– – 0.01% 520
2021
Q2 		$516K Hold
2,004
– – 0.01% 527
2021
Q1 		$601K Buy
+2,004
New +$624K 0.01% 531
2019
Q2 		– Sell
-313
Closed -$158K – 605
2019
Q1 		$158K Hold
313
– – ﹤0.01% 567
2018
Q4 		$154K Hold
313
– – ﹤0.01% 574
2018
Q3 		$287K Sell
313
-27
-8% -$23K 0.01% 564
2018
Q2 		$249K Buy
+340
New +$392K 0.01% 566

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

South Dakota Investment Council's NKTR Position: Q2 2022 in Review

South Dakota Investment Council sold out of Nektar Therapeutics (NKTR) in Q2 2022, closing a stake of 2,004 shares — an estimated $162K sold.

South Dakota Investment Council first reported a position in NKTR in Q2 2018 and held it in 9 quarters. The position peaked at $601K in Q1 2021. 228 funds tracked by Wall St. Rank hold NKTR as of Q2 2022.

  • South Dakota Investment Council reported no remaining Nektar Therapeutics position as of Q2 2022 after selling out during the quarter.
  • South Dakota Investment Council sold 2,004 Nektar Therapeutics shares in Q2 2022, an estimated $162K.
  • South Dakota Investment Council first reported a position in Nektar Therapeutics in Q2 2018 and held it in 9 quarters.
  • South Dakota Investment Council's Nektar Therapeutics position peaked at $601K in Q1 2021.
  • 228 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2022.

Based on South Dakota Investment Council's 13F filing for Q2 2022, filed 11 Aug 2022.